Member Info for ShearClass

Magicalali you seem to be clueless, why on earth would you have £20k in a share like this?! You've shafted yourself with sheer stupidity...

Ha, I agree... shall be left to his own devices going forwards.

Back on topic, did you see the update from Mount Sinai last week on the Antibody testing? On track be the first quantitative test to receive FDA EUA...

https://www.mountsinai.org/about/newsroom/2020/mount-sinai-seeks-eua-from-food-and-drug-administration-for-potential-quantitative-serologic-test-for-covid19-pr

Wow, a scientific journal has already been published comparing the data / methodology RENX released earlier this month with other techniques for CKD prediction? Did you help out with the peer review process?

Totally agree Mrbadexample, the fundementals here are exceptional and due to macro factors should continue to improve (sadly for the health of the world). Doubt Wbernard will buy in properly until they have a test that has 100% PPV, or is he going to develop his own? Ha.

Fingers crossed they win the award...

When you net debt is 10x your sales pipeline you're in a very dangerous position, clearly individuals buying here have no regard for financial statements...

The below is actually unbelievable, accruing interest at 10% on a €45m balance and then converting into shares - talk about a nice little earner!

“Further included within non-current borrowings as at year end are amounts of £40,006k (2018: £32,806k) due to Mr Falih Nahab, a brother of Dr Faiz Nahab, a director of the Company. This balance includes principal loan advances of €41.1m (2018: €30.3m) and accrued interest thereon. The principal loan attracts interest of 10% per annum and is unsecured. Mr Falih Nahab has the option to convert the accrued interest at any time into Ordinary shares in the parent company at varying rates per share. Subsequent to the year end it was agreed to extend this loan facility by a further €3.6m, from €41.1m to €44.7m.”

Regardless of the potential for the future, a market cap of £363m cannot be justified by a revenue of £760k and an order book of £6.2m. Oh and a whopping great debt balance as well... Of all of the energy plays on AIM, this is by far and away the most overvalued IMO. Back to reality after these results I think.

I’ve come to the conclusion that the 2.5m trade at 9p on Friday had to be a buy - there was a delayed sell after the close for 600k at 8.45am priced at 8.65. No chance you could sell 4 x that amount for a premium when the SP was only briefly over 9p.

@Comeonvog, you did say it would be typical for the price to fall after it was printed in order to generate sells to fill the buy order - the fall certainly happened on very little visible selling so that fits the theory.

If my assumptions are correct I expect to see the SP have a strong day tomorrow and close between 8.5-9p. Certainly in the current renewable energy environment this share offers unbelievable value, all TPG need is one big electrolyser contract and they will double in value overnight as the crowd arrives, fingers crossed we’re ahead of the curve!

The question is, when do the masses realise that TPG is now a hydrogen / renewables play? You just need to look at their LinkedIn feed this week to see where their focus is - 3 x posts last week on hydrogen. Volume has already increased to levels last seen in 2008-10, and I do feel as though a serious breakout day is around the corner.

Yep, 2.5m just went through at 9p...

That 1.7m is a sell, no other trades today were below 7.80, thankfully it appears to be connected to the end of the persistent seller - hence the rise this afternoon :)

Exactly! France is moving up again at last, be good to close above €2.90 that's for sure.

Bit of volume starting to come in...I agree that I think we'll see a steady rise here over the rest of the year - certainly back to the £5 range, as there are only 29m shares in issue this still only puts the company at £150m market cap.

Ghia, enough of your cross ramping of GDR - it is miles behind NCYT from a regulatory point of view, literally miles. The CEO basically confirmed last week that they can only sell in Europe at present - you aren’t going to be exporting to India without a specific country license - which by the way NCYT already have. Likewise distribution & production are nowhere near, and NCYT has £120m + of sales vs £0 for GDR.

It’s like comparing a push bike with a motorbike at present

My very unscientific opinion is that the market makers / powers that be are trying to frustrate as many existing holders as possible into selling. A lot of people made significant amounts back in Feb / March & now they are trying to balance the books by making those who bought in the £3-5 range give up and take a loss. This tactic will only work until we get hard financial confirmation of profit levels - potentially in the July half year trading update? Either way, the window where we can drift is narrowing.

The drop down on Euronext is infuriating, if we finish the day red it will be beyond belief! Initially the European volume was a blessing, but it's now become a real problem. I can't help but think that if this was only traded on AIM the price would be significantly higher right now.

@EXMEX, where did you get the data on time savings from?

Being held back by block selling on every rise - it happened throughout last week and the same this morning. Once the overhang clears it'll rise into double figures, until then it's a fantastic opportunity to load up.

Should be the start of sustained recovery back to £4+, still a bargain at these levels. Executing on promised news is always impressive, and this news has immediate revenue implications unlike the usual patter from AVCT

johnnykipper, you seem like an eternal pessimist, if it's such a terrible share then just sell and find something else to buy / moan about?